Medifast, Inc. MED
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- +17.32%
- 1 year
- +4.24%
- Open
- 12.36
- Prev close
- 12.15
- Mkt cap
- 140.12M
- Vol
- 93.65K
- Avg vol
- 143.63K
- EPS
- -3.70
- P/E
- 0.00
- Div yield
- 34.41%
More statistics
- Low
- 12.25
- High
- 12.58
- Forward P/E
- 56.17
- Beta
- 1.16
- Short ratio
- 7.68
- Inst. own
- 86.16%
- Dividend
- 6.60
- Ex-div date
- Sep 17, 2023
- 50-d avg
- 18.72
- 200-d avg
- 22.71
- 1y target
- 16.50
5Y chart
Events in this range
- Dec 20, 2021Dividend: 1.42
- Mar 28, 2022Dividend: 1.64
- Jun 27, 2022Dividend: 1.64
- Sep 19, 2022Dividend: 1.64
- Dec 19, 2022Dividend: 1.64
- Feb 7, 2023Dividend: 1.64
- Mar 27, 2023Dividend: 1.65
- Jun 26, 2023Dividend: 1.65
- Aug 7, 2023Earnings: 2.77; estimate 1.44; surprise 92.36%
- Sep 18, 2023Dividend: 1.65
- Oct 13, 2023Rating: Stephens & Co. · — → Equal-Weight
- Nov 6, 2023Earnings: 2.12; estimate 1.02; surprise 107.84%
- Feb 20, 2024Earnings: 1.09; estimate 0.99; surprise 10.1%
- Feb 21, 2024Rating: DA Davidson · Neutral → Neutral
- Apr 29, 2024Earnings: 0.66; estimate 0.78; surprise -15.38%
- Apr 30, 2024Rating: DA Davidson · Neutral → Neutral
- Jun 5, 2024Downgrade: DA Davidson · Neutral → Underperform
- Jul 22, 2024Rating: DA Davidson · Underperform → Underperform
- Aug 5, 2024Earnings: 0.92; estimate 0.36; surprise 155.56%
- Nov 4, 2024Earnings: 0.35; estimate -0.15; surprise 333.33%
- Nov 5, 2024Rating: DA Davidson · Underperform → Neutral
Signals (91)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Oct 27, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 22, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Jun 30, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| SMA: Bearish | Dec 9, 2024 | 1 year ago |
| SMA: Bullish | Dec 2, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 11, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| RSI: Oversold | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 15, 2024 | 2 years ago |
| RSI: Oversold | Jan 15, 2024 | 2 years ago |
| SMA: Bearish | Dec 11, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| RSI: Oversold | Nov 6, 2023 | 2 years ago |
| MACD: Sell Signal | Sep 18, 2023 | 3 years ago |
| SMA: Bearish | Aug 14, 2023 | 3 years ago |
| SMA: Bearish | Jul 31, 2023 | 3 years ago |
| SMA: Bullish | Jul 24, 2023 | 3 years ago |
| SMA: Bullish | Jun 19, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 19, 2023 | 3 years ago |
| RSI: Oversold | Jun 5, 2023 | 3 years ago |
| RSI: Oversold | May 22, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 3, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 27, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Jan 16, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Nov 14, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| RSI: Oversold | Oct 31, 2022 | 4 years ago |
| RSI: Oversold | Sep 12, 2022 | 4 years ago |
| RSI: Oversold | Aug 15, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 1, 2022 | 4 years ago |
| SMA: Bearish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Jun 27, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
| SMA: Bearish | May 16, 2022 | 4 years ago |
| SMA: Bullish | May 2, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Apr 11, 2022 | 4 years ago |
| RSI: Oversold | Feb 14, 2022 | 4 years ago |
| SMA: Bearish | Jan 10, 2022 | 4 years ago |
Key statistics
- Market cap
- 184.30M
- Enterprise value
- 27.90M
- Trailing P/E
- 25.15
- Forward P/E
- 56.17
- PEG ratio
- 0.00
- Price / sales
- 0.27
- Price / book
- 0.87
- EPS (TTM)
- 0.67
- Beta
- 1.16
- Dividend yield
- 34.41%
- Payout ratio
- 0.00%
- Profit margin
- 1.09%
- Revenue (TTM)
- 674.48M
- Revenue growth
- -40.60%
- Free cash flow
- -7.09M
- Total cash
- 169.96M
- Total debt
- 17.63M
- Return on equity
- 3.66%
- Shares outstanding
- 10.94M
- Short % of float
- 22.52%
- 50-day average
- 18.72
- 200-day average
- 22.71
Analyst view
Consensus: none
- Target (low)
- 16.00
- Target (mean)
- 16.50
- Target (high)
- 17.00
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.16.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2024 | Sep 1, 2024 | -0.15 | 0.35 | +0.50 | +333.33% |
| Aug 5, 2024 | Jun 1, 2024 | 0.36 | 0.92 | +0.56 | +155.56% |
| Apr 29, 2024 | Mar 1, 2024 | 0.78 | 0.66 | -0.12 | -15.38% |
| Feb 20, 2024 | Dec 1, 2023 | 0.99 | 1.09 | +0.10 | +10.10% |
| Nov 6, 2023 | Sep 1, 2023 | 1.02 | 2.12 | +1.10 | +107.84% |
| Aug 7, 2023 | Jun 1, 2023 | 1.44 | 2.77 | +1.33 | +92.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2024 | DA Davidson | up | Underperform | Neutral |
| Jul 22, 2024 | DA Davidson | main | Underperform | Underperform |
| Jun 5, 2024 | DA Davidson | down | Neutral | Underperform |
| Apr 30, 2024 | DA Davidson | main | Neutral | Neutral |
| Feb 21, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 13, 2023 | Stephens & Co. | init | — | Equal-Weight |
About Medifast, Inc.
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
- Sector
- Consumer Cyclical
- Industry
- Personal Services
- Country
- United States
- Website
- medifastinc.com
News
- Medifast Is Running The Same Playbook, And I Have The Same Concerns
- Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises
- Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript
- What Medifast (MED) Said on Its Q3 Earnings Call
- Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates
- Medifast Q3 2026 Earnings Call Transcript
- Medifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est
- Medifast Sees FY2026 Adj EPS $(0.70)-$(0.45) vs $(0.94) Est; Raises FY2026 Sales Guidance from $270.000M-$300.000M to $280.000M-$300.000M vs $287.700M Est
- Medifast Q3 Adj. EPS $(0.19) Beats $(0.35) Estimate, Sales $72.048M Beat $71.300M Estimate
- Medifast Sees Q4 GAAP EPS $0.00-$0.25 vs $(0.12) Est; Sees Sales $55.000M-$75.000M vs $64.100M Est
Your note
Sign in to keep a note on MED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN JEFFREY J. | Director | Stock Award(Grant) | Jun 19, 2024 | 22,193 |
| CHARD DANIEL R | Chief Executive Officer | Stock Award(Grant) | Mar 12, 2024 | 211,828 |
| GEARY ELIZABETH A. | Director | Stock Award(Grant) | Jun 19, 2024 | 8,377 |
| HALLQUIST CONSTANCE J | Former | Sale | Oct 5, 2023 | 0 |
| HOER MICHAEL A. | Director | Stock Award(Grant) | Jun 19, 2024 | 14,971 |
| MACKENZIE JONATHAN BARRETT | Officer | Stock Award(Grant) | Mar 12, 2024 | 4,051 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 9.20% | 1,006,210 | 16.95M | Sep 29, 2024 |
| Blackrock Inc. | 8.01% | 876,114 | 14.76M | Sep 29, 2024 |
| Vanguard Group Inc | 6.64% | 726,167 | 12.24M | Sep 29, 2024 |
| AQR Capital Management, LLC | 3.52% | 384,598 | 6.48M | Sep 29, 2024 |
| Morgan Stanley | 2.93% | 321,007 | 5.41M | Sep 29, 2024 |
| Bank of America Corporation | 2.88% | 314,728 | 5.30M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.26% | 356,866 | 6.01M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.68% | 292,768 | 4.93M | Oct 30, 2024 |
| Avantis U.S. Small Cap Value ETF | 1.84% | 201,586 | 3.40M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.48% | 162,005 | 2.73M | Sep 29, 2024 |
| Vanguard Consumer Staples Index Fund | 1.17% | 127,545 | 2.15M | Aug 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 1.15% | 125,563 | 2.12M | Jul 30, 2024 |